| Dr Judith Hendrickson, OD | |
|
4592 Jefferson Davis Hwy, Beech Island, SC 29842-4872 | |
| (803) 593-4508 | |
| (803) 593-4504 |
| Full Name | Dr Judith Hendrickson |
|---|---|
| Gender | Female |
| Speciality | Optometrist |
| Location | 4592 Jefferson Davis Hwy, Beech Island, South Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750304507 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | OPT001593 (Georgia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Judith Hendrickson, OD 4592 Jefferson Davis Hwy, Beech Island, SC 29842-4872 Ph: (803) 593-4508 | Dr Judith Hendrickson, OD 4592 Jefferson Davis Hwy, Beech Island, SC 29842-4872 Ph: (803) 593-4508 |
News Archive
Alkermes plc today announced positive topline results from a randomized, double-blind, placebo-controlled phase 3 clinical trial of aripiprazole lauroxil in patients with schizophrenia. Patients treated once monthly with either 441 mg or 882 mg of aripiprazole lauroxil demonstrated statistically significant reductions from baseline in Positive and Negative Syndrome Scale (PANSS) total scores at week 12, compared to placebo (p<0.001 aripiprazole lauroxil 441 mg, p<0.001 aripiprazole lauroxil 882 mg), which was the prespecified primary endpoint in the study. Based on the positive results from this phase 3 study, Alkermes plans to submit a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) in the third quarter of 2014.
Nearly three years of research have brought about remarkable results for the majority of 80 patients subjected to targeted alpha therapy of metastatic prostate cancer.
GenVec, Inc. today announced a new agreement for the supply of services relating to development materials with Novartis, related to the companies' collaboration in hearing loss and balance disorders. Under this new agreement, GenVec could receive approximately $13 million over four years to manufacture clinical trial material for up to two lead candidates.
Two studies in The Journal of General Physiology (JGP) help pave the way for a "shortcut" model-free approach to studying activation of "polymodal" ion channels-channels that open in response to multiple stimuli. Transmembrane ion channels respond to various physiological stimuli to regulate numerous cellular functions. Different classes of channels respond to different types of stimuli; some channels, for instance, respond to changes in membrane potential whereas others are activated by ligand binding.
BMG LABTECH's visual appearance is heading into a new direction. The microplate reader company launched a new corporate colour identity that will be rolled out across all products as well as external and internal communication channels in the coming weeks.
› Verified 9 days ago
Family Eyecare Center Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4592 Jefferson Davis Hwy, Beech Island, SC 29842 Phone: 803-593-4508 Fax: 803-593-4504 |